The EMA's Management Board said it postponed formal adoption of the policy on publication of clinical trial data to its Oct. 2, 2014, meeting. Further clarification on working and practical arrangements will be discussed by board members, who have confirmed their general support to the overall aims and objectives of the policy, including the more user-friendly amendments proposed by EMA Executive Director Guido Rasi that would allow data to be downloaded, saved or printed for academic and noncommercial research purposes. (See BioWorld Today, Jan. 7, 2014.)